Vol.57 No.S-1 March 2009

In vitro antimicrobial activity of tebipenem

Keiko Yamada, Toshie Sugano, Nobuyoshi Baba, Yoshihiro Takayama, Takeshi Mikuniya and Kazunori Maebashi

Jpn. J. Chemother. 57 (S-1): 1-14, 2009

Mechanism for tebipenem antimicrobial activity against Streptococcus pneumoniae and Haemophilus influenzae

Toshie Sugano, Keiko Yamada, Nobuyoshi Baba, Koju Itahashi, Takayoshi Fukushima, Takashi Ida and Kazunori Maebashi

Jpn. J. Chemother. 57 (S-1): 15-29, 2009

In vitro tebipenem activity against anaerobic bacteria

Kaori Tanaka and Kunitomo Watanabe

Jpn. J. Chemother. 57 (S-1): 30-37, 2009

Antimicrobial activity of tebipenem pivoxil against Streptococcus Pneumoniae and Haemophilus Influenzae, and its pharmacokinetic-pharmacodynamic profile in mice

Toshie Sugano, Takuji Yoshida, Keiko Yamada, Atsuyuki Shimizu, Jun Morita, Koji Kijima, Kazunori Maebashi and Shigeki Shibasaki

Jpn. J. Chemother. 57 (S-1): 38-48, 2009

Real-time PCR detection of causative microorganisms in pediatric patients with acute otitis media in clinical phase III tebipenem-pivoxil studies

Kimiko Ubukata, Miyuki Morozumi, Naoko Chiba and Keiko Hamano-Hasegawa

Jpn. J. Chemother. 57 (S-1): 49-57, 2009

Antibiotic susceptibility and resistance gene analysis of Streptococcus Pneumoniae in clinical tebipenem-pivoxil studies in pediatric patients using PCR method

Kimiko Ubukata, Naoko Chiba, Miyuki Morozumi and Keiko Hamano-Hasegawa

Jpn. J. Chemother. 57 (S-1): 58-66, 2009

Antibiotic susceptibility and resistance gene analysis of Haemophilus Influenzae in clinical tebipenem-pivoxil studies in pediatric patients using PCR method

Kozue Kishii, Naoko Chiba, Miyuki Morozumi, Keiko Hamano-Hasegawa and Kimiko Ubukata

Jpn. J. Chemother. 57 (S-1): 67-75, 2009

Coincidence of Streptococcus Pneumoniae or Haemophilus Influenzae isolated simultaneously in epipharynx and middle-ear fluids in pediatric patients with acute otitis media

Kozue Kishii, Naoko Chiba, Miyuki Morozumi, Keiko Hamano-Hasegawa and Kimiko Ubukata

Jpn. J. Chemother. 57 (S-1): 76-81, 2009

Pharmacokinetics and safety of oral carbapenem antibiotic tebipenem pivoxil tablets in healthy male volunteers

Mitsuyoshi Nakashima, Jun Morita and Kazumasa Aizawa

Jpn. J. Chemother. 57 (S-1): 82-89, 2009

Pharmacokinetics and safety of tebipenem pivoxil fine granules, an oral carbapenem antibiotic, in healthy male volunteers

Mitsuyoshi Nakashima, Jun Morita and Kazumasa Aizawa

Jpn. J. Chemother. 57 (S-1): 90-94, 2009

Effect of diet including ice cream and pudding on tebipenem pivoxil fine granules pharmacokinetics in healthy male volunteers

Mitsuyoshi Nakashima, Jun Morita and Kazumasa Aizawa

Jpn. J. Chemother. 57 (S-1): 95-98, 2009

Effect of gastric pH-raising drugs on tebipenem pivoxil fine granules pharmacokinetics in healthy male volunteers

Mitsuyoshi Nakashima, Jun Morita and Kazumasa Aizawa

Jpn. J. Chemother. 57 (S-1): 99-102, 2009

Effect of probenecid or diet on tebipenem pivoxil tablets pharmacokinetics in healthy male volunteers

Mitsuyoshi Nakashima, Jun Morita and Kazumasa Aizawa

Jpn. J. Chemother. 57 (S-1): 103-108, 2009

Pharmacokinetics and safety of tebipenem pivoxil tablets in healthy volunteers and in patients with reduced renal function

Mitsuyoshi Nakashima, Jun Morita and Kazumasa Aizawa

Jpn. J. Chemother. 57 (S-1): 109-114, 2009

An open clinical study of tebipenem pivoxil in children with acute otitis media and acute upper respiratory tract infection (Phase II)

Keisuke Sunakawa, Noboru Yamanaka, Satoshi Iwata, Kyoichi Totsuka, Yoshio Aizawa, Seiji Hori, Naoichi Iwai and Kimiko Ubukata

Jpn. J. Chemother. 57 (S-1): 115-124, 2009

A open clinical trial study of tebipenem pivoxil fine granule for treatment of pediatric patients with otolaryngological infections

Noboru Yamanaka, Satoshi Iwata, Kyoichi Totsuka, Yoshio Aizawa, Seiji Hori, Naoichi Iwai, Kimiko Ubukata and Keisuke Sunakawa

Jpn. J. Chemother. 57 (S-1): 125-136, 2009

An open clinical study of tebipenem pivoxil in children with bacterial pneumonia

Satoshi Iwata, Kazunobu Ouchi, Naoichi Iwai, Akira Watanabe, Kyoichi Totsuka, Seiji Hori, Yoshio Aizawa, Kimiko Ubukata and Keisuke Sunakawa

Jpn. J. Chemother. 57 (S-1): 137-150, 2009

General study of tebipenem pivoxil in children with acute otitis media and acute rhinosinusitis (Phase III)

Shunkichi Baba, Kenji Suzuki, Kyoichi Totsuka, Seiji Hori, Kimiko Ubukata and Keisuke Sunakawa

Jpn. J. Chemother. 57 (S-1): 151-166, 2009

Double-blind comparative study of tebipenem pivoxil and high-dose cefditoren pivoxil in children with acute otitis media (Phase III)

Kenji Suzuki, Shunkichi Baba, Kyoichi Totsuka, Seiji Hori, Kimiko Ubukata, Mitsuyoshi Nakashima and Keisuke Sunakawa

Jpn. J. Chemother. 57 (S-1): 167-185, 2009

PK-PD analysis of tebipenem pivoxil in clinical trials for pediatric patients

Kyoichi Totsuka, Kazumasa Aizawa, Jun Morita, Seiji Hori, Satoshi Iwata and Keisuke Sunakawa

Jpn. J. Chemother. 57 (S-1): 186-191, 2009

Safety profile of tebipenem pivoxil, a new oral carbapenem, in pediatric patients

Seiji Hori and Keisuke Sunakawa

Jpn. J. Chemother. 57 (S-1): 192-204, 2009